Krystal Biotech (KRYS) Cash & Equivalents Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 36.53% |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn | 52.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.72% |
| Dec 31, 2025 | 45.27% |
| Sep 30, 2025 | 28.18% |
| Jun 30, 2025 | 17.39% |
| Mar 31, 2025 | 4.66% |
| Dec 31, 2024 | 0.35% |
| Sep 30, 2024 | 9.27% |
| Jun 30, 2024 | 1.62% |
| Mar 31, 2024 | -3.71% |
| Dec 31, 2023 | 10.13% |
| Sep 30, 2023 | 9.75% |
| Mar 31, 2023 | -7.91% |
| Dec 31, 2022 | -4.78% |
| Sep 30, 2022 | -1.46% |
| Jun 30, 2022 | 5.44% |
| Mar 31, 2022 | 40.06% |
| Dec 31, 2021 | 48.75% |
| Sep 30, 2021 | 83.13% |
| Jun 30, 2021 | 99.00% |
| Mar 31, 2021 | 104.21% |
| Dec 31, 2020 | 75.55% |
| Sep 30, 2020 | 75.13% |
| Mar 31, 2020 | 354.23% |
| Dec 31, 2019 | 360.28% |
| Sep 30, 2019 | 688.09% |